Nuwellis Inc (NUWE) Stock Price, Quote & News

Company Profile

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. wa...

Industry: Medical Devices

Sector: Healthcare

Phone: 952 345 4200

Website: www.nuwellis.com

Address:

12988 Valley View Road, Eden Prairie, United States

seazest Aug. 24 at 3:51 PM

$NUWE They are really testing people's patience. Over one week ago I mentioned that they could take it to 1.10 but it seems they may try to take it to 1 dollar at some point in time before any decent bounce.

0 · Reply

K55555 Aug. 24 at 9:43 AM

$NUWE another round to join.... in!

0 · Reply

bazooka007 Aug. 22 at 6:36 AM

$NUWE According to official figures from the Q2 financial report (August 2026), NUWE has secured sufficient cash runway to last through the second quarter of 2027. NUWE now has the financial flexibility to advance FDA approval for younger children (5 kg+) in the fourth quarter and prepare the new Clarity Prime system for 2027.

0 · Reply

coolcoo Aug. 21 at 11:36 PM

$NUWE

0 · Reply

Stonk_Scalper Aug. 21 at 6:29 PM

$NUWE is it really green

0 · Reply

thomasirons Aug. 21 at 6:20 PM

$NUWE Clarification: Supposedly NUWE sold those 1.3 Million common shares to INSTITUTIONAL INVESTORS @ $2.59 three weeks ago?

1 · Reply

thomasirons Aug. 21 at 4:31 PM

$NUWE And the public is supposed to believe that NUME made a registered direct offering 3 weeks ago of 1.3 million common shares at $2.59 per share?

1 · Reply

Rick2058 Aug. 21 at 3:12 PM

$NUWE Watching for close above 1.18 with increasing volume. May indicate reversal. If not, early next week.

0 · Reply

Joebeemer Aug. 21 at 3:03 PM

$NUWE seems like all these biotech companies trading for about $1.X just all seems to look like more of the same thing. It's like that turd floating all day you forgot to flush before you left home that day. Still waiting for you until you flush

0 · Reply

seazest Aug. 21 at 2:02 PM

$NUWE Volume only 40k . Some people do not realize the meaning of it. Most selling has been done suckers. LOL

0 · Reply

Nuwellis files to sell 1.35M shares of common stock for holders

Aug 18, 2026, 8:00 AM EDT - 6 days ago

Nuwellis Registration statement: Registration filing

Aug 13, 2026, 9:00 AM EDT - 11 days ago

Nuwellis Earnings Call Transcript: Q2 2026

Aug 13, 2026, 9:00 AM EDT - 11 days ago

Nuwellis Earnings release: Q2 2026

Aug 13, 2026, 9:00 AM EDT - 11 days ago

Nuwellis Quarterly report: Q2 2026

Aug 13, 2026, 8:00 AM EDT - 11 days ago

Nuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded Gross Margin

Aug 6, 2026, 8:30 AM EDT - 18 days ago

Nuwellis Strengthens Product Development Organization with Appointment of Dale Brady as Principal R&D Engineer

Aug 4, 2026, 8:30 AM EDT - 20 days ago

Nuwellis Announces Next-Generation Aquadex Platform Strategy to Expand Future Critical Care Applications

2026-07-31T13:21:06.000Z - 24 days ago

Nuwellis prices $3.4M at-the-market offering at $2.59 per share

Jul 31, 2026, 8:39 AM EDT - 24 days ago

Nuwellis Announces Pricing of $3.4 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

2026-07-30T13:17:04.000Z - 25 days ago

Why Is Penny Stock Nuwellis (NUWE) Up Today?

Jul 30, 2026, 8:00 AM EDT - 25 days ago

Nuwellis Announces Acceptance by Frontiers in Pediatrics of New Single-Center Retrospective Study Supporting Alternative Anticoagulation Strategy for Aquadex Ultrafiltration Therapy

Jul 28, 2026, 8:00 AM EDT - 27 days ago

Nuwellis Expands Pediatric Footprint with First Aquadex SmartFlow® Installations in Wisconsin

Jul 27, 2026, 8:30 AM EDT - 4 weeks ago

Nuwellis Announces Preliminary Revenue Results for the Second Quarter 2026 Showing Double Digit Growth

2026-07-16T12:35:27.000Z - 5 weeks ago

Nuwellis awarded U.S. patent for Dual Lumen Catheter

Jul 16, 2026, 8:30 AM EDT - 5 weeks ago

Nuwellis Awarded U.S. Patent for Novel Catheter Technology Designed to Enhance Extracorporeal Therapies

Jul 7, 2026, 8:00 AM EDT - 6 weeks ago

Nuwellis to Showcase Aquadex Therapy at KidneyBee Summit 2026

Jul 7, 2026, 8:00 AM EDT - 6 weeks ago

Nuwellis Proxy statement: Proxy filing

Jun 26, 2026, 8:00 AM EDT - 2 months ago

Nuwellis Celebrates Five Years of Support of the Pediatric Cardiac Critical Care Consortium (PC⁴)

Jun 26, 2026, 8:00 AM EDT - 2 months ago

Nuwellis Proxy statement: Proxy filing

2026-06-25T23:50:12.000Z - 2 months ago

Nuwellis Inc trading halted, news pending

Jun 25, 2026, 8:30 AM EDT - 2 months ago

Nuwellis Announces Pediatric Expansion in Michigan with First Aquadex SmartFlow® Installations

Jun 24, 2026, 8:30 AM EDT - 2 months ago

Incoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders

2026-06-18T12:51:14.000Z - 2 months ago

Nuwellis highlights clinical utility of its Aquadex SmartFlow system

Jun 18, 2026, 8:30 AM EDT - 2 months ago

Nuwellis Expands Critical Care Education with Aquadex Training at University of Minnesota Critical Care Cardiology Education Summit

2026-06-16T12:50:42.000Z - 2 months ago

Nuwellis CEO transition to transition out of role, Mike McCormick to succeed

Jun 16, 2026, 8:30 AM EDT - 2 months ago

Nuwellis Appoints Mike McCormick as Chief Executive Officer

2026-06-10T12:50:10.000Z - 2 months ago

Nuwellis expands collaboration with South Carolina healthcare system

Jun 10, 2026, 8:30 AM EDT - 2 months ago

Nuwellis Expands Collaboration with Major South Carolina Healthcare System to Install New Aquadex SmartFlow® Devices at One of its Children's Hospitals

Jun 8, 2026, 9:46 PM EDT - 2 months ago

Nuwellis Announces Closing of $6.0 Million Registered Public Offering

2026-06-05T12:56:35.000Z - 2 months ago

Nuwellis 20M share secondary priced at 30c

Jun 5, 2026, 8:30 AM EDT - 2 months ago

Nuwellis Announces Pricing of $6 Million Public Offering

Jun 4, 2026, 8:00 AM EDT - 2 months ago

Nuwellis Registration statement: Registration filing

Jun 2, 2026, 7:00 AM EDT - 2 months ago

Nuwellis Slides: Investor presentation

May 29, 2026, 8:00 AM EDT - 3 months ago

Nuwellis Registration statement: Registration filing

2026-05-22T21:15:44.000Z - 3 months ago

Nuwellis files to sell 4.85M shares of common stock, warrants

May 22, 2026, 8:00 AM EDT - 3 months ago

Nuwellis Registration statement: Registration filing

2026-05-14T14:09:24.000Z - 3 months ago

Nuwellis completes Aquadex SmartFlow System pre-submission meeting with the FDA

May 14, 2026, 8:30 AM EDT - 3 months ago

Nuwellis Announces Successful Completion of FDA Pre-Submission 510(k) Meeting to Expand Aquadex Label

May 12, 2026, 9:00 AM EDT - 3 months ago

Nuwellis Earnings Call Transcript: Q1 2026

May 12, 2026, 9:00 AM EDT - 3 months ago

Nuwellis Earnings release: Q1 2026

May 12, 2026, 9:00 AM EDT - 3 months ago

Nuwellis Quarterly report: Q1 2026

May 12, 2026, 8:00 AM EDT - 3 months ago

Nuwellis, Inc. Announces First Quarter 2026 Financial Results

May 5, 2026, 8:00 AM EDT - 3 months ago

Nuwellis, Inc. To Announce First Quarter 2026 Financial Results on May 12, 2026

Apr 29, 2026, 8:30 AM EDT - 4 months ago

Nuwellis Highlights Case Study Featuring Precision Ultrafiltration Therapy in Pediatric Cardiorenal Care at ISHLT 2026 Annual Meeting

2026-04-28T13:19:54.000Z - 4 months ago

Nuwellis gets notice of allowance from USPTO for lumen midline catheter

Apr 28, 2026, 8:30 AM EDT - 4 months ago

Nuwellis Announces Receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for Innovative Dual Lumen Midline Catheter Technology

Apr 23, 2026, 8:30 AM EDT - 4 months ago

Nuwellis to Participate in the AATS 106th Annual Meeting and ERAS Cardiac Spring Retreat

Apr 21, 2026, 8:30 AM EDT - 4 months ago

Nuwellis Announces Aquadex Software Update

2026-04-16T12:51:56.000Z - 4 months ago

Nuwellis announces return of three former team members

Apr 16, 2026, 8:30 AM EDT - 4 months ago

Nuwellis Welcomes Back Three Former Team Members to Accelerate Commercial and Clinical Momentum

Apr 9, 2026, 8:30 AM EDT - 4 months ago

Nuwellis Engages CORE IR for Public Relations, Shareholder Communications, and Social Media Management Services

2026-04-07T13:45:21.000Z - 4 months ago

Nuwellis expands commercial footprint with new South Texas territory

Apr 7, 2026, 8:30 AM EDT - 4 months ago

Nuwellis Strengthens Commercial Infrastructure with New South Texas Territory

Apr 6, 2026, 8:00 AM EDT - 5 months ago

Nuwellis Proxy statement: Proxy filing

Apr 2, 2026, 8:00 AM EDT - 5 months ago

Nuwellis Proxy statement: Proxy filing

Mar 31, 2026, 8:30 AM EDT - 5 months ago

Nuwellis Pediatric Category Achieves Approximately 50% of Total U.S. Revenue in 2025, Marking Growth Milestone

2026-03-17T12:27:39.000Z - 5 months ago

Nuwellis completes acquisition of Rendiatech

Mar 17, 2026, 8:00 AM EDT - 5 months ago

Nuwellis Completes Acquisition of Rendiatech

Mar 10, 2026, 9:00 AM EDT - 5 months ago

Nuwellis Earnings Call Transcript: Q4 2025

Mar 10, 2026, 9:00 AM EDT - 5 months ago

Nuwellis Earnings release: Q4 2025

Mar 10, 2026, 9:00 AM EDT - 5 months ago

Nuwellis Annual report: Q4 2025

2026-03-10T12:21:07.000Z - 5 months ago

Nuwellis reports Q4 EPS ($1.50) vs ($18.30) last year

Mar 10, 2026, 8:15 AM EDT - 5 months ago

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

2026-03-05T13:26:40.000Z - 6 months ago

Nuwellis appoints Goldstein as Director of Clinical Strategy

Mar 5, 2026, 8:00 AM EST - 6 months ago

Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy

2026-02-26T13:12:57.000Z - 6 months ago

Nuwellis appoints McDonald, Emerson to board of directors

Feb 26, 2026, 8:00 AM EST - 6 months ago

Nuwellis Appoints David A. McDonald and Martin J.

Feb 24, 2026, 8:00 AM EST - 6 months ago

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026

Feb 17, 2026, 6:00 AM EST - 6 months ago

Nuwellis Slides: Investor presentation

Feb 4, 2026, 7:00 AM EST - 7 months ago

Nuwellis Registration statement: Registration Filing

2026-02-04T11:11:26.000Z - 7 months ago

Nuwellis files to sell 4.28M shares of common stock for holders

2026-01-30T13:25:28.000Z - 7 months ago

Nuwellis appoints Schultz as Chief Financial Officer

Jan 30, 2026, 8:00 AM EST - 7 months ago

Nuwellis Appoints Carisa Schultz as Chief Financial Officer

Jan 29, 2026, 4:36 PM EST - 7 months ago

Nuwellis Announces $5 Million Private Placement and Warrant Inducement Transaction, Priced At-The-Market

Jan 29, 2026, 4:35 PM EST - 7 months ago

Nuwellis Enters into Definitive Agreement to Acquire Rendiatech, Advancing Its Cardiorenal Portfolio Strategy

Jan 23, 2026, 4:40 PM EST - 7 months ago

Nuwellis Announces Changes to Board of Directors

Jan 6, 2026, 8:15 AM EST - 8 months ago

Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy

Dec 9, 2025, 8:15 AM EST - 9 months ago

Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings

Dec 4, 2025, 8:15 AM EST - 9 months ago

Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S.

Nov 12, 2025, 9:00 AM EST - 10 months ago

Nuwellis Earnings Call Transcript: Q3 2025

Nov 12, 2025, 9:00 AM EST - 10 months ago

Nuwellis Quarterly report: Q3 2025

Nov 12, 2025, 9:00 AM EST - 10 months ago

Nuwellis Earnings release: Q3 2025

Nov 12, 2025, 8:15 AM EST - 10 months ago

Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum

Nov 10, 2025, 9:00 AM EST - 10 months ago

Nuwellis Receives Notice of Allowance of a New U.S. Patent Strengthening Vivian™ Pediatric System with Advanced Clamp Safety Technology

Oct 23, 2025, 9:00 AM EDT - 10 months ago

Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025

Sep 30, 2025, 8:45 AM EDT - 11 months ago

Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®

Sep 18, 2025, 9:00 AM EDT - 1 year ago

Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration

Sep 17, 2025, 10:16 AM EDT - 1 year ago

Nuwellis, Inc. Participates in a Virtual Investor “What This Means” Segment

Sep 9, 2025, 9:00 AM EDT - 1 year ago

Nuwellis' Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio

Sep 4, 2025, 8:15 AM EDT - 1 year ago

Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management

Aug 21, 2025, 8:15 AM EDT - 1 year ago

Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter

Aug 19, 2025, 8:15 AM EDT - 1 year ago

Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company

seazest Aug. 24 at 3:51 PM

0 · Reply

K55555 Aug. 24 at 9:43 AM

$NUWE another round to join.... in!

0 · Reply

bazooka007 Aug. 22 at 6:36 AM

0 · Reply

coolcoo Aug. 21 at 11:36 PM

$NUWE

0 · Reply

Stonk_Scalper Aug. 21 at 6:29 PM

$NUWE is it really green

0 · Reply

thomasirons Aug. 21 at 6:20 PM

$NUWE Clarification: Supposedly NUWE sold those 1.3 Million common shares to INSTITUTIONAL INVESTORS @ $2.59 three weeks ago?

1 · Reply

thomasirons Aug. 21 at 4:31 PM

$NUWE And the public is supposed to believe that NUME made a registered direct offering 3 weeks ago of 1.3 million common shares at $2.59 per share?

1 · Reply

Rick2058 Aug. 21 at 3:12 PM

$NUWE Watching for close above 1.18 with increasing volume. May indicate reversal. If not, early next week.

0 · Reply

Joebeemer Aug. 21 at 3:03 PM

0 · Reply

seazest Aug. 21 at 2:02 PM

$NUWE Volume only 40k . Some people do not realize the meaning of it. Most selling has been done suckers. LOL

0 · Reply

seazest Aug. 21 at 1:59 PM

$NUWE I do not think people realize how this stock is setting up for a massive short squeeze. I said the same about JZ 2 days ago to load it heavily below 1.70s then yesterday it hit 5.47. I made over 300% profit in 5 days of adding it below 1.70s.

1 · Reply

El_Grande_Sniper Aug. 21 at 1:52 PM

$NUWE This could be the next mega-runner +1000%. Fall, fall, RS, straight line BOOM!!! I start adding slowly every day with patience.

0 · Reply

seazest Aug. 21 at 1:50 PM

$NUWE one of the lowest volume in awhile so it is time for another adding up as most selling has been done.

0 · Reply

seazest Aug. 21 at 12:26 PM

$NUWE I have been buying this since 1.20 and added more yesterday at 1.13 . Patience is needed here, the lower it goes and the longer it takes to run the bigger the run when it happens. My first target is 2.20.

0 · Reply

coolcoo Aug. 21 at 11:24 AM

$NUWE

0 · Reply

BellR Aug. 20 at 9:49 PM

$NUWE will pop soon

0 · Reply

MoneyMacG Aug. 20 at 6:38 PM

$VSME $INAB $YYAI $BON $NUWE good

0 · Reply

Stonk_Scalper Aug. 20 at 12:35 PM

$NUWE I do have some shares in my custodial account. Waiting if it would pop. But may sell for a loss soon. Dead volume everyday. And the SI data is never accurate enough. Company still doing atm and the algo has the spread way apart to break even.

1 · Reply

aku78 Aug. 20 at 9:51 AM

$NUWE totally agree. There are some unethical and crook people out there. This company is one of them along with $IPW. I pray they lose peace and tranquility in life for stealing from others

0 · Reply

done84 Aug. 20 at 4:38 AM

$NUWE should have been delisted long-long time ago!

0 · Reply

BankingBig Aug. 19 at 11:39 PM

$NUWE 😂😂😂😂😂

1 · Reply

BankingBig Aug. 19 at 11:38 PM

$NUWE this is why I never gave this stock a chance after a day being stuck and cut ties quickly.. because this is all these garbage tickers do is bleed and bleed till they can't bleed no more

0 · Reply

Market Cap	4.23M
Revenue (ttm)	8.27M
Net Income (ttm)	-17.52M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-211.85%
Debt to Equity Ratio	0.00

Volume	226,000
Avg Vol	3,716,922
Day's Range	N/A - N/A
Shares Out	3.65M
Stochastic %K	11%
Beta	0.31
Analysts	Strong Buy
Price Target	$11.00